COLORECTAL CANCER THERAPEUTICS MARKET challenges and opportunities

Colorectal cancer therapeutics market faces challenges like side effects associated with various treatment options. Common chemotherapeutic drugs can cause severe side effects like nausea, fatigue, hair loss, and peripheral neuropathy, significantly affecting patients' quality of life and sometimes leading to treatment discontinuation. Targeted therapies and immunotherapies can induce immune-related adverse events. Effective management of these side effects is crucial for improving adherence to therapy and clinical outcomes, necessitating focus on developing novel therapeutics with better safety profiles.

Market Opportunity - Advancement in the Colorectal Cancer (CRC) Treatment

Advancement in the colorectal cancer treatment offers significant opportunities. For instance, as per the New England Journal of Medicine in October 2022, a group of researchers enrolled 84,585 men and women aged 55 to 64 years old for colorectal cancer clinical trials who had not undergone prior colorectal cancer screening. The researchers noted that 15 participants experienced major bleeding after polyp removal. However, no perforations or screening-related deaths occurred within 30 days of colonoscopy.